ViiV Healthcare UK Ltd

Stockley Park West, Uxbridge, Middlesex,, UB11 1BT, UK
Telephone: +44 (0)800 221 441
Fax: +44 (0)208 990 4328
Patient Information Leaflet last updated on the eMC: 11/02/2010
PIL Kivexa film-coated tablets

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 11/02/2010 and displayed until Current
Reasons for adding or updating:
  • Change to date of revision
  • Change to drug interactions
  • Change to information about pregnancy or lactation
Updated on 15/12/2009 and displayed until 11/02/2010
Reasons for adding or updating:
  • Change to date of revision
  • Change to warnings or special precautions for use
  • Change to side-effects
Updated on 19/06/2009 and displayed until 15/12/2009
Reasons for adding or updating:
  • Change to date of revision
  • Change to warnings or special precautions for use
Updated on 23/04/2008 and displayed until 19/06/2009
Reasons for adding or updating:
  • Change to date of revision
  • Change to warnings or special precautions for use
Updated on 01/03/2007 and displayed until 23/04/2008
Reasons for adding or updating:
  • Change to warnings or special precautions for use
Updated on 05/01/2005 and displayed until 01/03/2007
Reasons for adding or updating:
  • New PIL for new product

Active Ingredients/Generics

 
   lamivudine
   abacavir sulfate


© 2010 Datapharm Communications Ltd

Go to www.medicines.org.uk